Analysis on the Implementation of Same Disease Same Price Policy within DRG Payment Reform in China
- VernacularTitle:我国DRG支付方式改革中同病同价政策实施现状分析
- Author:
Yuqing REN
1
;
Wei LI
;
Yifan CHEN
;
Mengru GE
;
Jinxi DING
Author Information
1. 中国药科大学国际医药商学院 江苏 南京 211198
- Publication Type:Journal Article
- Keywords:
Diagnosis Related Group Payment;
same disease same price;
hierarchical diagnosis and treatment
- From:
Chinese Health Economics
2024;43(12):27-32
- CountryChina
- Language:Chinese
-
Abstract:
In China,the cost weight of Diagnosis Related Group (DRG) payment generally adopts the historical data method. In order to adapt to medical costs at different levels of hospitals,medical insurance departments often set a grade coefficient to adjust the payment standard. However,the grade coefficient could solidify the"siphon effect"of high-level hospitals to some extent. In order to promote hierarchical diagnosis and treatment,some region select certain basic group which is suitable for treatment in primary hospitals,and cancel grade coefficient to achieve"same disease same price". It discusses the background and principle of same-disease-same-price policy,sorts out the current implementation status,analyzes the selection criteria and characteristics of basic DRG group and evaluates whether the selected groups coordinate policy principle,so as to provide references for improving the reform of DRG payment and promoting the hierarchical diagnosis and treatment system in China.
